Ziva DRA supports pharmaceutical, medical device, diagnostic and healthcare companies with international regulatory strategy, documentation coordination, dossier readiness and market-specific regulatory planning across global expansion programs.
Global regulatory affairs involves translating one product-development program into multiple market-specific regulatory pathways. Documentation that supports one jurisdiction may require adaptation, supplementation or restructuring for another.
Ziva DRA supports companies by reviewing product and manufacturer information, identifying target-market requirements, assessing dossier readiness and coordinating regulatory workstreams around the wider market-access strategy.
The engagement can be structured around a single international market or a broader multi-country program involving dossier preparation, GMP consulting, registration planning and continuing compliance.
The project scope depends on the product, target jurisdictions and existing regulatory documentation.
Review product status, manufacturer information, existing approvals and international expansion goals.
Structure the likely regulatory pathway for each selected target market.
Review available product documentation against anticipated international requirements.
Support preparation, organization and adaptation of regulatory documentation.
Coordinate connected regulatory activities across multiple jurisdictions.
Support relevant post-approval, renewal or regulatory-change workstreams.
A disciplined global regulatory process helps prioritize markets and align documentation before individual submissions begin.
Define target jurisdictions and commercial priorities.
Review regulatory pathways and product readiness.
Organize and adapt regulatory documentation.
Coordinate market-specific regulatory activities.
Support continuing lifecycle requirements.
International expansion becomes more efficient when core product information is organized before market-specific adaptation begins.
Establish the common regulatory foundation that supports assessment across multiple markets.
Each target jurisdiction should then be assessed for its own requirements and documentation expectations.
A coherent global strategy can reduce duplication while preserving the market-specific detail required for compliance.
Link individual country registrations to one broader regulatory roadmap.
Identify where core documentation may support multiple market workstreams.
Coordinate regulatory activity around commercial expansion priorities.
Consider post-approval requirements as part of market-entry planning.
Manufacturers planning international pharmaceutical registration programs.
Device manufacturers expanding into multiple regulated markets.
Companies requiring international regulatory and documentation coordination.
Regulatory and commercial teams developing multi-market expansion programs.
Yes. A regulatory program can be structured around one market or multiple target jurisdictions depending on the client's expansion strategy.
Not necessarily. Core documentation may be reusable, but individual jurisdictions can have different application and documentation requirements.
Yes. A dossier and market-gap review can help identify what is already available and what may require adaptation.
Yes. Dossier preparation, GMP consulting and regulatory strategy can be coordinated where they form connected parts of the same international market-access program.
Share your product portfolio, existing approvals, available dossier and target markets with Ziva DRA so the global regulatory pathway and market-specific workstreams can be assessed.